Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

522 public trials 245 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Recruiting

Anti-GD2 ADC M3554 in Advanced Solid Tumors

NCT06641908

Conditions
Advanced Solid Tumor, Astrocytoma, Glioblastoma, +10 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York - Memorial Sloan Kettering Cancer Center (CC)- Westc New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • UZ Leuven Leuven, Belgium
View Trial Details
Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

NCT06561685

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +21 more
Locations
  • UCLA Santa Monica, California, United States
  • University of Colorado Health Hospital Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
View all 33 locations
View Trial Details
Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 90 locations
View Trial Details
Recruiting

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

NCT07602842

Conditions
Advanced Solid Tumor, Anus Diseases, Anus Neoplasms, +33 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • START New York Long Island Lake Success, New York, United States
  • START Dallas Forth Worth Fort Worth, Texas, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Recruiting

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

NCT07213830

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • South Texas Accelerated Research Therapeutics (START) - Midwest Grand Rapids, Michigan, United States
  • Sarah Cannon Research Institute - Tennessee Oncology Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics (START) - San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

SW-682 in Advanced Solid Tumors

NCT06251310

Conditions
Adenoma, Advanced Solid Tumor, Lung Diseases, +12 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • UC San Diego Moores Cancer Center Sacramento, California, United States
  • UCLA Hematology-Oncology - Santa Monica Santa Monica, California, United States
View Trial Details
Recruiting

A Study of DS5361b in Participants With Advanced Solid Tumors

NCT07182591

Conditions
Advanced Solid Tumor
Locations
  • Research Site Sarasota, Florida, United States
  • Research Site Providence, Rhode Island, United States
  • Research Site Irving, Texas, United States
  • Research Site San Antonio, Texas, United States
View Trial Details
Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

NCT07070232

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +25 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California San Francisco San Francisco, California, United States
  • Hartford Healthcare Hartford, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 76 locations
View Trial Details
Recruiting

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

NCT06833008

Conditions
Advanced Solid Tumor
Locations
  • START Mid-West Grand Rapids, Michigan, United States
  • Sarah Cannon Research Institute (SCRI) - Nashville Nashville, Tennessee, United States
  • Mary Crowley Cancer Research Centers - Medical City Hospital - Dallas Dallas, Texas, United States
  • START Mountan Region West Valley City, Utah, United States
View all 13 locations
View Trial Details

Related conditions